The CDC peddled pseudo science in the middle of a pandemic
In a moment that reflects the ongoing reckoning between institutional authority and dissenting scientific voices, Jay Bhattacharya — the Stanford physician who challenged pandemic orthodoxy from the outside — has been placed at the helm of the very agency he once accused of peddling pseudoscience. His appointment as acting CDC director, while retaining his NIH leadership role, signals that the current administration is not merely adjusting public health policy but reconsidering its philosophical foundations. At a time when public trust in vaccine guidance has fallen by nearly half since 2020, the nation finds itself asking what it means for an institution to earn — and keep — the confidence of those it serves.
- The White House has installed Jay Bhattacharya, co-author of the Great Barrington Declaration and one of the CDC's most prominent critics, as the agency's acting director — a move that inverts the traditional relationship between institutional power and dissent.
- Public trust in CDC vaccine guidance has collapsed from 85% to 47% since early 2020, creating a volatile backdrop for any leader attempting to rebuild or reimagine the agency's credibility.
- The appointment follows the abrupt removal of confirmed CDC director Susan Monarez, who lasted less than a month before clashing with Health Secretary Robert F. Kennedy Jr. over vaccine policy — a warning that ideological alignment, not credentials alone, now governs tenure.
- Bhattacharya has stated he supports vaccination for childhood diseases including measles, but his history of opposing mandates and lockdowns suggests the CDC's public messaging and policy recommendations are headed for substantial revision.
- Public health experts are sounding alarms that rolling back vaccine guidance could trigger outbreaks of preventable diseases, while the administration frames the shift as a necessary correction to policies it argues lacked evidentiary grounding.
Jay Bhattacharya, the Stanford physician who spent the pandemic years arguing that government lockdowns caused more harm than they prevented, will now lead the Centers for Disease Control and Prevention on an acting basis — while continuing to serve as director of the National Institutes of Health. The White House announced the appointment this week, placing at the CDC's helm a figure who has publicly accused the agency of peddling pseudoscience in its pandemic guidance.
Bhattacharya replaces Jim O'Neill, who will be nominated to lead the National Science Foundation. The shuffle is part of a broader reorganization under Health Secretary Robert F. Kennedy Jr., whose central mission has been reshaping vaccine policy and pandemic response protocols. A permanent CDC director — a Senate-confirmed position — has yet to be named.
Bhattacharya rose to national prominence in October 2020 as co-author of the Great Barrington Declaration, which called for ending lockdowns in favor of focused protection of vulnerable populations. The declaration was sharply criticized by health officials at the time but elevated his profile and drew him into Kennedy's orbit. In subsequent years, he argued publicly that major pandemic policies — including school closures and vaccine mandates — lacked strong evidence and may have eroded public confidence in routine childhood vaccinations.
The appointment arrives against a backdrop of dramatically diminished public trust. A poll published this month found that only 47 percent of American adults trust the CDC for reliable vaccine information, down from 85 percent in early 2020. Bhattacharya has said he supports vaccination for childhood diseases and told a Senate hearing this month that vaccines remain the best tool against measles outbreaks — but his selection signals the administration intends to substantially revise how the CDC approaches and communicates vaccine policy.
The leadership turbulence at the CDC reflects deeper instability within the Department of Health and Human Services. Susan Monarez, confirmed as CDC director in July, was removed less than a month later after clashing with Kennedy over his vaccine agenda — a swift departure that made clear the administration's tolerance for internal resistance is limited. Bhattacharya's appointment suggests the White House believes it has found a leader whose vision for the agency is genuinely its own.
Jay Bhattacharya, a Stanford physician who spent the pandemic arguing that government shutdowns were too severe, will now run the Centers for Disease Control and Prevention. The White House announced the move this week, making Bhattacharya the acting director of an agency he has spent years criticizing for what he calls scientific overreach. He will hold the position while keeping his current job leading the National Institutes of Health.
Bhattacharya replaces Jim O'Neill, who had served as the CDC's acting director and will now be nominated to lead the National Science Foundation. The shuffle is part of a broader reorganization of health leadership under Health Secretary Robert F. Kennedy Jr., who has made reshaping vaccine policy and pandemic response protocols a central focus of his tenure. The administration says it is searching for a permanent CDC director, a role that requires Senate confirmation.
The appointment marks a significant ideological shift at an agency responsible for protecting Americans from disease outbreaks and setting vaccine recommendations. Bhattacharya rose to prominence in 2020 as a dissenting voice during the coronavirus crisis. He co-authored the Great Barrington Declaration, published that October, which called for an end to lockdowns and argued that focused protection of vulnerable populations was a better strategy. The declaration drew sharp rebukes from government health officials at the time, but it ultimately raised his profile and aligned him with Kennedy, who has long questioned the government's pandemic response.
In recent years, Bhattacharya has been direct in his criticism of the CDC. In a 2024 post on social media, he wrote that the agency "peddled pseudo science in the middle of a pandemic," referring specifically to its guidance on masking. Last month, he and other NIH leaders published a commentary in Nature Medicine arguing that major pandemic policies—lockdowns, school closures, vaccine mandates—lacked strong evidence and may have caused unintended harm, including eroding public confidence in routine childhood vaccinations.
The timing of the appointment is significant given the erosion of public trust in the CDC's vaccine guidance. A poll published this month found that just 47 percent of American adults now trust the agency for reliable information on vaccines, a dramatic drop from 85 percent in early 2020. That decline has occurred as Kennedy has worked to reshape the nation's vaccine recommendations, a push that has met resistance from public health experts who warn that rolling back vaccine guidance could endanger vulnerable populations.
Bhattacharya has said he supports vaccination for childhood diseases, including measles. At a Senate hearing this month, he stated that vaccination remains the best way to address measles outbreaks in the country. But his appointment signals that the administration intends to substantially revise how the CDC approaches vaccine policy and communicates about vaccines to the public. The agency's vaccine recommendations have become a political flashpoint, with Kennedy and his allies arguing they should be scaled back and with public health leaders warning that doing so could trigger outbreaks of preventable diseases.
The leadership instability at the CDC reflects deeper turbulence within the Department of Health and Human Services. Susan Monarez was confirmed as CDC director in July but was removed less than a month later after clashing with Kennedy over his vaccine agenda. Her rapid departure signaled that the administration would not tolerate resistance to its public health priorities. Bhattacharya's appointment suggests the White House believes it has found someone more aligned with its vision for the agency.
Citas Notables
The best way to address the measles epidemic in this country is by vaccinating your children for measles— Jay Bhattacharya, at a Senate hearing in February 2026
Many of the recommended policies, including lockdowns, social distancing, school closures, masking, and vaccine mandates, lacked robust confirmatory evidence— Bhattacharya and other NIH leaders, in Nature Medicine commentary, January 2026
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter who runs the CDC? Isn't it just a bureaucratic shuffle?
The CDC sets vaccine recommendations that millions of Americans follow. It also shapes how the country responds to disease outbreaks. If the person running it fundamentally disagrees with the agency's past guidance, that changes what Americans are told to do.
But Bhattacharya says he supports childhood vaccines. Isn't that reassuring?
He does support them in principle. But he's also argued that vaccine mandates damaged public trust in vaccines generally. The question is whether his leadership will lead to narrower vaccine recommendations or different messaging about which vaccines are necessary.
What's the Great Barrington Declaration, and why does it matter now?
It was a 2020 statement arguing that lockdowns were the wrong approach and that the focus should be on protecting the elderly and vulnerable while letting the virus spread through younger populations. It was controversial then. Now, the person who wrote it is running the agency that helped shape pandemic policy.
The poll showing 47 percent trust in CDC vaccines—is that because of what Kennedy is doing, or did it happen before?
The trust declined over the entire pandemic and after. But Kennedy's public criticism of vaccines and vaccine mandates has accelerated that decline. Now he's in a position to reshape the very guidance that eroded public trust in the first place.
What happens next?
Watch the CDC's vaccine recommendations. If they narrow significantly, or if the agency changes how it communicates about vaccines, you'll see whether this appointment was about course correction or about fundamentally remaking vaccine policy.